Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC-01 Nasal Spray in Chinese Patients with Dry Eye Disease
NCT05378945Phase 3Completed
- Sponsor
- CORXEL Pharmaceuticals
- Start
- Jul 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline in dry eye disease (DED), sponsored by CORXEL Pharmaceuticals. Started Jul 2022; status: completed.
02
Drugs
varenicline
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05378945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05378945.